Carnegie slashes Bavarian Nordic share target

The investment bank has also changed its recommendation for investors of the Danish biotech company to ”hold” their investments.
Photo: Sven Hoppe/AP/Ritzau Scanpix
Photo: Sven Hoppe/AP/Ritzau Scanpix
by marketwire, translated by daniel pedersen

Bavarian Nordic is no longer on Carnegie’s list of what to buy as the investment bank has lowered its recommendation from ”buy” to ”hold,” according to Bloomberg News.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must contain at least 6 characters
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading